NLRP3 and atherosclerosis: In summary, our data indicated that SM22 promoter-driven sterol-resistant SCAP in VSMCs promotes the secretion of inflammatory factors via the upregulation of NLRP3 expression, which subsequently leads to endothelial injury and ultimately accelerates the occurrence and development of atherosclerosis.